Literature DB >> 9331235

Markers for macrophage and osteoclast lineages in giant cell lesions of the oral cavity.

J C Tiffee1, T B Aufdemorte.   

Abstract

PURPOSE: Giant cell lesions of the oral cavity are a well recognized entity. However, the histogenesis of these lesions is still the subject of controversy, with support for both histiocyte/macrophage and osteoclast origins being found in the literature. This study evaluated a set of peripheral giant cell lesions (PGCLs) and central giant cell lesions (CGCLs) for characteristics of both cell types to address this dilemma.
MATERIALS AND METHODS: Detection of histiocyte/macrophage characteristics was accomplished immunohistochemically by evaluating for markers specific for this cell type, namely alpha-1 -antichymotrypsin (1 -ACT) and factor XIIIa antibodies. Detection of osteoclast characteristics made use of the fact that osteoclasts possess a unique enzyme, tartrate-resistant acid phosphatase, which can be appreciated by histochemical procedures.
RESULTS: A large percentage of the multinucleated cells stained with the 1-ACT (38.08% in PGCLs and 15.84% in CGCLs), while only isolated cells stained for factor XIIIa (1.20% PGCLs, 0.99% CGCLs). Isolated stromal cells also were stained. Virtually all multinucleated cells reacted with the tartrate-resistant acid phosphatase stain (99.26% PGCLs, 98.34% CGCLs), as did a number of the mononuclear stromal cells.
CONCLUSIONS: This study supports the contention that GCLs of the oral cavity may arise from precursor cells related to the granulocyte/macrophage line, and may originate from mononuclear cells that express markers for both macrophages and osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331235     DOI: 10.1016/s0278-2391(97)90291-3

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  7 in total

Review 1.  Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases.

Authors:  J E O'Connell; G J Kearns
Journal:  Ir J Med Sci       Date:  2012-10-26       Impact factor: 1.568

2.  Peripheral giant cell granuloma associated with a dental implant: a case report and review of the literature.

Authors:  Amy Louise Brown; Paulo Camargo de Moraes; Marcelo Sperandio; Andresa Borges Soares; Vera Cavalcanti Araújo; Fabrício Passador-Santos
Journal:  Case Rep Dent       Date:  2015-03-16

3.  Inflammatory Morbidity due to Compound Mandibular Body Fractures: Does It Have a Relationship with Treatment Outcome?

Authors:  Charles E Anyanechi; Birch D Saheeb
Journal:  Med Princ Pract       Date:  2015-03-14       Impact factor: 1.927

4.  Immunohistochemical expression of Src protein in peripheral and central giant cell granulomas of the jaws.

Authors:  Monir Moradzadeh Khiavi; Amir Ala Aghbali; Monireh Halimi; Maryam Kouhsoltani; Hamed Hamishehkar
Journal:  J Oral Maxillofac Pathol       Date:  2013-09

5.  Central giant cell granuloma of the jaws and giant cell tumor of long bones: an immunohistochemical comparative study.

Authors:  Maria do Socorro Aragão; Marta Rabello Piva; Cassiano Francisco Weege Nonaka; Roseana de Almeida Freitas; Lélia Batista de Souza; Leão Pereira Pinto
Journal:  J Appl Oral Sci       Date:  2007-08       Impact factor: 2.698

6.  A Comparative Study of Cathepsin D Expression in Peripheral and Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique.

Authors:  Massoumeh Zargaran; Abbas Moghimbeigi; Noushin Afsharmoghadam; Mohsen Nasr Isfahani; Atefeh Hashemi
Journal:  J Dent (Shiraz)       Date:  2016-06

7.  A comparative study of osteopontin and MMP-2 protein expression in peripheral and central giant cell granuloma of the jaw.

Authors:  Nooshin Mohtasham; Nasrollah Saghravanian; Bahareh Fatemi; Mehdi Vahedi; Monavar Afzal-Aghaee; Hamideh Kadeh
Journal:  Braz J Otorhinolaryngol       Date:  2017-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.